DNTH
Dianthus Therapeutics, Inc. Common Stock
stockNASDAQ
magenta therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases. by creating a platform focused on key areas of transplant medicine, magenta therapeutics is pioneering an integrated, but modular approach to stem cell therapies that reboot the blood and immune systems to create patient benefit. founded by internationally recognized leaders in stem cell transplant medicine, magenta therapeutics was launched in 2016 by third rock ventures and atlas venture and is headquartered in cambridge, mass. for more information, please visit www.magentatx.com.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 87.83 | 2026-09-28 | +0.50% | -0.282 |
| 1M | 108.10 | 2026-09-04 | -18.34% | 0.993 |
| 3M | 93.34 | 2026-07-06 | -5.43% | 0.582 |
| 6M | 85.50 | 2026-04-06 | +3.24% | 0.831 |
| 1Y | 34.94 | 2025-10-03 | +152.63% | 0.872 |
| 2Y | 28.00 | 2024-10-04 | +215.25% | — |
| 5Y | 12.51 | 2023-09-13 | +605.60% | 1.076 |
Dianthus Therapeutics, Inc. Common Stock (NASDAQ:DNTH) stock price today is $88.27, and today's volume is 751,386. DNTH is down 0.057% today. The 30 day average volume is 784,176. DNTH market cap is $4.94B with 55.93M shares outstanding.